Company intelligence / Profile preview

Unibio

Roskilde; Kalundborg, Region Zealand/Roskilde area/Kalundborg area, Denmarkunibio.dk ↗

Ownership: Private
Development stage: Commercial

Overview

Unibio has developed and commercialized a proprietary fermentation process that converts methane gas into high-quality microbial protein ("Uniprotein®"), primarily for use as animal feed. The process uses significantly less water than traditional plant or animal-based proteins and can be deployed in decentralized facilities. The company has pilot/demo plants in Denmark and industrial projects underway internationally. No clinical results as it does not develop human therapeutics.

Modalities: Microbial proteinSingle cell protein
Industry: Agriculture & AgTech

Drug pipeline

1 asset

Uniprotein

Commercial

Indications: Animal feed, Aquaculture

Partnerships

Saudi Industrial Investment Group (strategic investor/acquirer of minority stake)

Beyond the preview

Go deeper on Unibio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Unibio.

Explore the full profile